Urokinase receptor (CD87) aggregation triggers phosphoinositide hydrolysis and intracellular calcium mobilization in mononuclear phagocytes

Journal of Immunology

Volumn 163, Issue 11, 1999, Pages 6193-6200

  Sitrin, Robert G ^a,c   Pan, Pauline M ^a   Harper, Hollie A ^a   Blackwood, R Alexander ^a   Todd III, Robert F ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; INOSITOL 1,4,5 TRISPHOSPHATE; INTEGRIN; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; PROTEIN TYROSINE KINASE; UROKINASE RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CAPPING PHENOMENON; CROSS LINKING; HUMAN; HUMAN CELL; MONOCYTE; MONONUCLEAR PHAGOCYTE; PRIORITY JOURNAL;

BENZOQUINONES; CALCIUM SIGNALING; CELL ADHESION; CELL MOVEMENT; ESTRENES; HUMANS; HYDROLYSIS; IMMUNOLOGIC CAPPING; INOSITOL 1,4,5-TRISPHOSPHATE; LACTAMS, MACROCYCLIC; LEUKOTRIENE B4; MACROPHAGE-1 ANTIGEN; MONOCYTES; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPASE C; PROTEIN-TYROSINE KINASES; PYRROLIDINONES; QUINONES; RECEPTORS, CELL SURFACE; THAPSIGARGIN; U937 CELLS;

EID: 0033486026     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Schleiffenbaum, B., and J. Fehr. 1996. Regulation and selectivity of leukocyte emigration. J. Lab. Clin. Med. 127:151.
2. Andreasen, P. A., L. Kjoller, L. Christensen, and M. J. Duffy. 1997. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72:1.
3. Blasi, F. 1997. uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? Immunol. Today 18:415.
4. Gyetko, M., R. Todd III, C. Wilkinson, and R. Sitrin. 1994. The urokinase receptor is required for monocyte chemotaxis in vitro. J. Clin. Invest. 93:1380.
5. Sitrin, R., R. Todd, H. Petty, T. Brock, S. Shollenberger, E. Albrecht, and M. Gyetko. 1996. The urokinase receptor (CD87) facilitates CD11b/CD 18-mediated adhesion of human monocytes. J. Clin. Invest. 97:1942.
6. Wei, Y., M. Lukashev, D. Simon, S. Bodary, S. Rosenberg, M. Doyle, and H. Chapman. 1996. Regulation of integrin function by the urokinase receptor. Science 273:1551.
7. 2 integrins in vivo. J. Exp. Med. 188:1029.
8. Cao, D., I. Mizukami, B. Gami-Wagner, A. Kindzelskii, R. Todd, L. Boxer, and H. Petty. 1995. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release: possible roles of complement receptor type III and calcium. J. Immunol. 154:1817.
9. Kirchheimer, J. C., and H. G. Remold. 1989. Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes. J. Immunol. 143:2634.
10. Gyetko, M., R. Sitrin, J. Fuller, R. Todd, and T. Standiford. 1995. Function of the urokinase receptor (CD87) in PMN chemotaxis. J. Leukocyte Biol. 58:533.
11. 2 integrins, and src-kinases within a single receptor complex of human monocytes. J. Exp. Med. 181:1381.
12. Dumler, I., A. Weis, O. A. Mayboroda, C. Maasch, U. Jerke, H. Haller, and D. C. Gulba. 1998. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J. Biol. Chem. 273:315.
13. Koshelnick, Y., M. Ehart, P. Hufnagl, P. C. Heinrich, and B. R. Binder. 1997. Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J. Biol. Chem. 272: 28563.
14. Xue, W., A. Kindzelskii, R. Todd, and H. Petty. 1994. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J. Immunol. 152:4630.
15. Ciambrone, G., and P. McKeown-Longos. 1992. Vitronectin regulates the synthesis and localization of urokinase-type plasminogen activator in HT-1080 cells. J. Biol. Chem. 267:13617.
16. Del Rosso, M., E. Anichini, N. Pedersen, F. Blasi, G. Fibbi, M. Pucci, and M. Ruggiero. 1993. Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. Biochem. Biophys. Res. Commun. 190:347.
17. Anichini, E., G. Fibbi, M. Pucci, R. Caldini, M. Chevanne, and M. DelRosso. 1994. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor. Exp. Cell Res. 213:438.
18. Anichini, E., A. Zamperini, M. Chevanne, R. Caldini, M. Pucci, G. Fibbi, and M. Del Rosso. 1997. Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters. Biochemistry 36:3076.
19. Rabbani, S. A., J. Gladu, A. P. Mazar, J. Henkin, and D. Goltzman. 1997. Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase. J. Cell. Physiol. 172:137.
20. Nguyen, D. H., I. M. Hussaini, and S. L. Gonias. 1998. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J. Biol. Chem. 273:8502.
21. Tang, H., D. M. Kerins, Q. Hao, T. Inagami, and D. E. Vaughan. 1998. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells. J. Biol. Ckem. 273:18268.
22. Resnati, M., M. Guttinger, S. Valcamonica, N. Sidenius, F. Blasi, and F. Fazioli. 1996. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J. 15:1572.
23. Shetty, S., A. Kumar, A. R. Johnson, and S. Idell. 1995. Regulation of mesothelial cell mitogenesis by antisense oligonucleotides for the urokinase receptor. Antisense Res. Dev. 5:307.
24. Rabbani, S. A., A. P. Mazar, S. M. Bernier, M. Haq, I. Bolivar, J. Henkin, and D. Goltzman. 1992. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J. Biol. Chem. 267:14151.
25. Ploug, M., E. Rønne, N. Behrendt, A. Jensen, F. Blasi, and K. Danø. 1991. Cellular receptor for urokinase plasminogen activator: carboxy-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J. Biol. Chem. 266:1926.
26. Kirchheimer, J. C., Y. H. Nong, and H. G. Remold. 1988. IFN-γ, tumor necrosis factor-α, and urokinase regulate the expression of urokinase receptors on human monocytes. J. Immunol. 141:4229.
27. Sitrin, R., R. Todd III, I. Mizukami, T. Gross, S. Shollenberger, and M. Gyetko. 1994. Cytokine specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes. Blood 84:1268.
28. Plesner, T., M. Ploug, V. Ellis, E. Rønne, G. Høyer-Hansen, M. Wittrup, T. Linhardt-Pedersen, T. Tscheming, K. Danø, and N. Ebbe-Hansen. 1994. The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood 83:808.
29. Estreicher, A., J. Muhlhauser, J. Carpentier, L. Orci, and J. Vassalli. 1990. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J. Cell Biol. 111:783.
30. Myohanen, H. T., R. W. Stephens, K. Hedman, H. Tapiovaara, E. Rønne, G. Hoyer-Hansen, K. Dano, and A. Vaheri. 1993. Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. J. Histochem. Cytochem. 41:1291.
31. Kindzeiskii, A. L., Z. O. Laska, R. F. Todd III, and H. R. Petty. 1996. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (αM β2′ CD11b/CD18) during neutrophil polarization. J. Immunol. 156:297.
32. Min, H., R. Semnani, I. Mizukami, K. Watt, R. Todd III, and D. Liu. 1992. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J. Immunol. 148:3636.
33. Dana, N., B. Styrt, J. D. Griffin, R. F. Todd III, M. S. Klempner, and M. A. Arnaont. 1986. Two functional domains in the phagocyte membrane glycoprotein Mol identified with monoclonal antibodies. J. Immunol. 137:3259.
34. Sanchez-Madrid, F., J. Nagy, E. Robbins, P. Simon, and T. Springer. 1983. A human leukocyte differentiation antigen family with distinct α subunits and a common β subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM-1/Mac-1), and the p 150,95 molecule. J. Exp. Med. 158:1785.
35. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440.
36. 2+. Biochem. J. 269:513.
37. Mizukami, I., B. Garni-Wagner, L. deAngelo, M. Lieben, A. Flint, D. Lawrence, R. Cohen, and R. Todd. 1994. Immunologic detection of the cellular receptor for urokinase plasminogen activator Clin. Immunol. Immunopathol. 71:96.
38. Putney, J. W. Jr., and G. S. Bird. 1993. The inositol phosphate-calcium signaling system in nonexcitable cells. Endocr. Rev. 14:610.
39. 2+)-ATPases. Trends Phamacol. Sci. 19:131.
40. Smith, R. J., L. M. Sam, J. M. Justen, G. L. Bundy, G. A. Bala, and J. E. Bleasdale. 1990. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J. Pharmacol. Exp. Tner. 253:688.
41. Rhee, S. G., and Y. S. Bae. 1997. Regulation of phosphoinositide-specinc phospholipase C isozymes. J. Biol. Chem. 272:15045.
42. Kamat, A., and G. Carpenter. 1997. Phospholipase C-γl: regulation of enzyme function and role in growth factor-dependent signal transduction. Cytokine Growth Factor Rev. 8:109.
43. Pugin, J., V. V. Kravchenko, J. D. Lee, L. Kline, R. J. Ulevitch, and P. S. Tobias. 1998. Cell activation mediated by glycosylphosphatidylinositol-anchored or transmembrane forms of CD14. Infect. Immun. 66:1174.
44. Stefanova, I., V. Horejsi, I. Ansotegui, W. Knapp, and H. Stockinger. 1991. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254:1016.
45. 2+ signalling through leukocyte CD11b/CD18 integrin. Biochem. J. 288:465.
46. 2+, exocytosis of azurophilic granules, quantitative up-regulation of CD18, shedding of L-selectin, and actin polymerization. J. Leukocyte Biol. 56:625.
47. Wei, Y., D. Waltz, N. Rao, R. Drummond, S. Rosenberg, and H. Chapman. 1994. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:32380.
48. Colman, R. W., R. A. Pixley, S. Najamunnisa, W. Yan, J. Wang, A. Mazar, and K. R. McCrae. 1997. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J. Clin. Invest. 100:1481.
49. Kindzelskii, A. L., M. M. Eszes, R. F. Todd III, and H. R. Petty. 1997. Proximity oscillations of complement type 4 (αX β2) and urokinase receptors on migrating neutrophils. Biophys. J. 73:1777.
50. Ciambrone, G., and P. McKeown-Longo. 1990. Plasminogen activator inhibitor type 1 stabilizes vitronectin-dependent adhesions in HT-1080 cells. J. Cell Biol. 111:2183.
51. Waltz, D., and H. Chapman. 1994. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem. 269:14746.
52. Franco, P., C. Iaccarino, F. Chiaradonna, A. Brandazza, C. lavarone, M. R. Mastronicola, M. L. Nolli, and M. P. Stoppelli. 1997. Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility. J. Cell Biol. 137:779.
53. Stahl, A., and B. M. Mueller. 1995. The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J. Cell Biol. 129:335.
54. Shaul, P. W., and R. G. Anderson. 1998. Role of plasmalemmal caveolae in signal transduction. Am. J. Physiol. 275:1843.